Introduction
Cancer is one of the leading causes of death worldwide. As estimated by American Cancer Society, in 2018, in United States only, there will be 1,7 million newly diagnosed cancer cases and over a third of these cancer patients will die, with breast cancer significantly contributing to these statistics [1] . In more than fifty percent of cancer patients ionizing radiation, together with chemotherapy and surgery, is an integral part of a comprehensive cancer treatment [2] . However, for many types of cancers radiation therapy is efficient only if used at high doses and this approach often results in toxicity to the surrounding normal tissue, causing early and late side effects that can reduce the quality of life in patients [3] . Since first documented in the late 19 th century, radiation-induced cytotoxicity has been a major limiting factor in maximizing deposited radiation doses to the cancer tissues, and as such a significant obstacle in cancer treatment planning [4] . Enhancing therapeutic ratio of radio-treatment, i.e., delivering higher doses of radiation to the tumor itself, while minimizing damage to the surrounding normal tissue, has achieved significant milestones over the last few years through development in Intensity Modulated Radiation Therapy and Volumetric Modulated Arc Therapy [5, 6] . In addition, therapeutic ratio enhancement can be achieved by increasing the cancer cells sensitivity to irradiation; hence, radio-sensitizers as modulators of tumor response to irradiation has been an emerging field of research, with a particular focus on exploitation of nanoparticles [7, 8] .
Nanoparticles (NPs) are 1-100 nm constructs with a tremendous diagnostic and therapeutic potential for various types of diseases. In recent decades many advances have been made in the field of nanoparticles research that lead to the development of a variety of nanostructures for biomedical use. Depending on the application that can span from disease diagnosis to targeted drug delivery, nanoparticles are constructed from different materials and in different forms such as polymeric, liposome based, dendrimers metals as well as hybrid. For example, liposome-polymeric hybrid nanoparticles showed promising use as immunotherapeutic agent with a potential application in noncancerous and cancerous diseases [9] [10] [11] [12] [13] , while metal nanoparticles are more frequently explored as imaging and sensitizing probes enhancing radiation therapy [14] . Cancer research has been particularly interested in application of metal based nanoparticles for imaging, targeted drug delivery and radio sensitization in various cancers [15, 16] . Metal based NPs can increase the radio sensitivity of cancer cells by increasing local radiation dose deposition using differential absorption coefficient of high atomic number material, compared to the soft tissue [17, 18] . Among many metal NPs, gold NPs (AuNPs) have been proposed as particularly attractive radiosensitizers due to their unique physicochemical properties. It is well established that synthetic chemistry of colloidal AuNPs allows precise tailoring of particle size and shape for optimal tissue delivery [19] as well as surface functionality for bio-conjugation to drugs and agents that specifically target tumor cell [20] . Gold NPs can easily enter the systemic circulation and infiltrate tumor tissues, and once inside the tumor they enhance the irradiation effect [14] . In addition, they have low systemic clearance that together with well absorption, contributes to an enhanced permeation and retention effect (EPR) [21, 22] . It has also been demonstrated that NPs containing gold have higher dose enhancement compared to NPs containing other materials due to high atomic number (Z) of gold that provides for a large photoelectric cross section and high probability of secondary electron production [23] . However, this photoelectric effect is most dominant at low, kilo voltage (kV) energy levels at which it causes a significant increase in the absorbed dose [24, 25] . Yet, with few exceptions, kV energies are rarely used in a clinical setting where for most radiotherapies megavoltage (MV) X-rays are necessary to provide proper dose deposition to deepseated tumors and avoid skin damage [26] . Theoretical predictions by previous studies based on Monte Carlo modeling indicated low dose enhancement with AuNP at MV energies due to the predominance of Compton Effect and pair electron production [27] and consequently a lack of radio-sensitization. Contrary to these predictions, several studies provided evidence on radio-sensitization by AuNP at clinically relevant MV energies. Jain et al. demonstrated radio-sensitization by AuNPs in breast cancer MDA-MB-231 cells using 160 kV, 6 MV and 15 MV energies [28] . Radio-sensitization effects of AuNP at 6 MV was also shown in cancer cells of gastric [29] and cervical [30] origin, as well as in geometric model of tumor blood vessel endothelial cells [31] . These controversial, experimentally observed AuNP radio-sensitizing effects using MV energies may partially be explained by work in DNA plasmid models showing AuNP induced DNA damage by short range, low energy Auger electrons that can deposit high local doses in the vicinity of NP [32] and these electrons can be produced by ionizing radiation at MV energies as well. However, it is still not clear whether cytotoxicity observed at MV energies can be solely attributed to MV induced ionization events within the AuNPs, or factors such as direct chemical and/or biological AuNP interaction with cellular processes also play a role. Given that most previous in vitro studies have focused on AuNP radio-sensitizing properties at 6 MV megavoltage energy (MV) and that 2.5 MV energy has been introduced to imaging application while 10M V has been used for treatment on TrueBeam Linear Accelerator (Varian Medical System, Palo Alto, CA), we explored the AuNP effects using 2.5 MV and 10 MV energies and benchmarked it against 160 kV.
Regardless of the underlying mechanisms, for radio-sensitization to take place, AuNPs have to be taken up by the cell. Translocation of AuNPs across the cell membrane can be achieved via passive translocation or active endocytosis [33] , the later resulting in endosomal/lysosomal AuNP intracellular processing [34, 35] . Nanoparticles smaller than 10 nm are more likely to be taken up by passive process, while the receptor mediated endocytic pathway is typical for the larger ones and is associated with a better cellular uptake [33, 36] . Once inside the cells AuNPs are trapped inside the endo-and lysosomal vesicles with no free AuNPs within the cytosol or nucleus [34, 37] . However, some reports indicated that that both, smaller and larger NPs can reside in nucleus or in cytosol as free particles as well [38, 39] . Overall, the final intracellular localization is determined by AuNPs cell surface functionalization that in turn largely depends on NP size, shape, surface charge, ligand modification, NP aggregation as well as the cell type. In addition, all these variables can also profoundly affect AuNPs biodistribution and biocompatibility and have been studied by different investigators, often reporting inconclusive and controversial results. Larger size AuNPs, have been reported to be less efficient in penetrating and evenly distributing within the tumor tissue and are more readily captured by macrophages and accumulated in liver [36, 40] . On the other hand, AuNPs smaller than 5 nm in size tend to be rapidly eliminated through kidneys [41] and are more toxic at the cellular level [42, 43] . Still, currently, there is no consensus on the ideal, clinically relevant AuNP size. In the light of current knowledge, we opted for AuNPs of 4 nm and 14 nm in size, anticipating optimal cell uptake with minimal toxicity, while ensuring biocompatibility.
Radiation-induced cell damage involves oxidative stress as one of the main mechanisms that is facilitated through the production of reactive oxygen species (ROS) that can directly damage DNA or through oxidation of cell proteins and lipids and mitochondrial impairment, initiate apoptosis and necrosis [44] . The most lethal form of DNA damage, DNA double-strand breaks (DSB) can lead to cell cycle arrest, redistribution of DNA repair factors and apoptosis [45] . One of the first responses to double-strand DNA breaks is the phosphorylation of 139 Serine in histone H2AX, a DNA packaging protein important for the recruitment of DNA repair machinery, with the numbers of phosphorylated H2AX molecules linearly increasing with the severity of the damage [46] . Enhancement of DNA DSBs has been indicated as a possible mechanism in AuNP induced radio sensitization by studies where phosphorylation of histone H2AX was used as an assessment of DNA damage [47] .
Given the body of evidence on therapeutic potential of AuNP in clinically relevant settings the purpose of this study was to explore, in vitro, radio sensitization potential of AuNPs of 4 and 14 nm sizes with clinically relevant MV photons in MCF-7 breast cancer cell line. We chose the 4 nm and 14 nm core size because they are within the size range of suggested optimums for most efficient cellular uptake, accumulation and distribution within the tumors [48] and least possibility for cellular and systemic toxicity [49] . We investigated the differences in cellular uptake and intracellular localization between 4 and 14 nm AuNP by transmission electron microscopy (TEM). We also examined the effect of these AuNPs on MCF-7 cells response to irradiation by analyzing cell proliferation using MTT assay, and H2AX phosphorylation as an indicator of DNA DSBs by flow cytometry.
Materials and Methods
Gold nanoparticle (AuNP) synthesis and characterization Materials: Gold (III) chloride trihydrate (HAuCl 4 ·3H 2 O, 99% metal trace), sodium citrate tribasic dehydrate (≥99%), mercaptosuccinic acid (MSA, 97%), and sodium borohydride (NaBH 4 , 98%) were all purchased from Sigma-Aldrich. Sodium hydroxide (NaOH, 98%) was purchased from Fisher Scientific.
AuNP synthesis: MSA coated AuNP4 (AuNP with diameter of 4 nm) was synthesized following a modified method previously reported by our group [50] . The synthesis process started with a 250 ml scale reaction that involved a mixture of 0.25 × 10 -3 M HAuCl 4 ·3H 2 O and 0.25 × 10 -3 M tri-sodium citrate dissolved in deionized water vigorously stirred at room temperature. Addition of 7.5 mL ice cold 0.1 M NaBH 4 solution changed the color of the solution into wine-red. After 30 min of stirring, 25 mg of MSA was added after adjusting the pH of solution to 11, using 0.1 M NaOH solution. To ensure complete ligand exchange the solution was continuously stirred for overnight. The solution was then purified and concentrated by centrifugation, using MW10K Millipore Amicon centrifugal columns, to the final concentration of 2 mg/ml. MSA coated AuNP14 (AuNP with diameter of 14 nm) was synthesized following the Turkevich method [51] [52] [53] [54] . In a typical 250 ml scale reaction, 0.25 × 10 -3 M HAuCl 4 ·3H 2 O was dissolved in deionized water and then heated to boil under vigorous stirring. Preheated 87.5 mg of trisodium citrate dissolved in 15 mL deionized water was then added to the solution. After the color changed to winered, heating was continued for 25 min while stirring. Solution was then cooled down, the pH of solution was adjusted to 11 and 25 mg of MSA added. Solution was then stirred overnight to ensure the complete ligand exchange. MW10 K Millipore Amicon centrifugal columns were used to purify and concentrate the solution after the reaction was done. The final concentration was 2 mg/ml.
AuNP characterization: Upon completion of AuNPs synthesis, NPs were analyzed using JEOL JEM-2010 Transmission Electron Microscope (TEM) at the voltage of 200 kV and current of 109 mA. Energy dispersive x-ray analysis (EDXA) spectrum was acquired on EDAX PV9756/70 ME EDS system attached to the TEM. The samples were prepared by applying a droplet of AuNP solution on a Formvarcoated copper grid. The averaged particle size was determined by measuring at least 50 particles. Dynamic light scattering (DLS) and zeta potential measurements were performed using a Malvern Nano-ZS. A 1 mL solution was transferred to a 2.0 mL polystyrene cuvette. The Z-average hydrodynamic diameter (HD), polydispersity index (PDI), and zeta potential were measured at 25°C. 15 scans were performed in each measurement. The backscattering angle Θ was fixed at 172° with a laser wavelength λ=633 nm. The size measurement range was set between 1 nm and 6 μm. HD is a function of the diffusion coefficient (D), temperature (T), and viscosity (η) according to the Stokes-
, where k is Boltzmann constant, T is room temperature (25°C), and D was obtained from autocorrelation function via the cumulant fitting. The electrophoretic mobility of the nanoparticles was measured using the laser Doppler velocimetry and phase analysis light scattering technique of the Malvern Zetasizer. The electrophoretic mobility was converted into zeta potential by Smoluchowski equation, using the Malvern software [55] . Chemical composition of AuNPs was determined by thermogravimetric analysis (TGA) that was performed on TGA-Q50 instrument (TA company), using air as the working gas with the temperature range of 100-800°C and a heating rate of 10°C/min.
MCF-7 cell culture:
MCF-7 breast cancer cells were cultured in high glucose Dulbecco's modified Eagle's medium (Gibco, MD) supplemented with 10% fetal bovine serum and 5% penicillinstreptomycin (Invitrogen). Cells were maintained in a tissue culture incubator at 37°C with 5% CO 2 . Cells were passaged every 3-4 days.
Cell exposure to nanoparticles: Twenty four hours prior to the exposure to AuNPs, MCF-7 cells were plated in 96 or 6 well cell culture dishes with total of 3 × 10 3 or 3-5 × 10 5 cells per well, respectively. Cells were cultured o/n in a tissue culture incubator at 37°C with 5% CO 2. The next day cell were treated for 3 hours with either 4 or 14 nm AuNPs, diluted at various concentrations in a complete growth media. Four nm size AuNP was added at the concentrations of 3.9 × 10 12 particles per ml (p/ml), 7.8 × 10
12 p/ml, 1.56 × 10 13 p/ml or 3.12 × 10 13 p/ml, while 14 nm size AuNP was used at 9 × 10 10 p/ml, 1.8 × 10 11 p/ml, 3.6 × 10 11 p/ml or 7.2 × 10 11 p/ml.
Cell irradiation:
The cells were irradiated with 2 Gy, 4 Gy and 8 Gy at set energies: 160 kV, 2.5 flattening filter free (FFF) MV (60 MU/min) or 10 FFF MV (2400 MU/min) x-rays. The irradiation at MV energies was performed using linear accelerator (Varian, Palo Alto, Ca), while for 160 kV energy we used Faxitron 160 kV x-ray source (Wheeling, WV).
Analysis of AuNP cellular uptake by transmission electron microscopy (tem) and inductively coupled plasma mass spectrometry (ICP-MS)
A total of 5 × 10 5 cells were plated in 6 well cell culture plates and cultured for 24 h. Cells were then exposed for 3 hours to AuNPs. Four nm size AuNPs were added at the concentrations of 3.9 × 10 12 p/ml or 3.12 × 10 13 p/ml, while 14 nm size AuNPs were used at 9 × 10 10 p/ml or 7.2 × 10 11 p/ml. Following exposure, cells were washed twice in 1× phosphate-buffered saline (PBS), and prepared for TEM as previously described [50] . In brief, cells were fixed in in 2.5% glutaraldehyde in 0.1 M Phosphate Buffer, pH 7.4 (Electron Microscopy Sciences, Hatfield, PA) for 1 hour at room temperature. Cells were then scraped of the plates, centrifuged at a low speed and suspended in 2.5% glutaraldehyde. Samples were further processed at the Michigan State University (MSU) Center for Advanced Microscopy by post-fixation in 1% osmium tetroxide, rinsing in distilled water, and dehydration through a graded series of acetone. At the end samples were embedded in epoxy resin and cut into 70 nm sections that were then analyzed and photographed by JEOL 100CXII electron microscope. For ICP-MS analysis cell pellets were first digested by 1 ml of aqua regia (0.75 ml hydrochloric acid (HCl) and 0.25 ml nitric acid (HNO 3 )). The concentration of gold metal in digested cells was analyzed using an Agilent 7700x ICP-MS with an Agilent ASX-500 Series Autosampler. Prior to the analysis, external calibration using a series of standards with an internal standard correction of bismuth (Bi) was performed. Standards were purchased from High Purity Standards (Charleston, SC). To prevent precipitation or gold onto the surfaces of the instrument a rinse solution of 2% HCl (v/v) was used. Saline blank solution was used as a negative control. Total amount of gold determined in each sample was used to calculate the total amount of gold per cell. The number of nanoparticles per cell was calculated by dividing the total amount of gold per cell by the known mass of a single AuNP.
Proliferation assay:
Prior to the experiment, MCF-7 cells were grown to 75% confluence after which they were plated in 96 well plates, 3000 cells per well in 100 ul of complete DMEM growth media. Twenty four hours later, growth media was replenished and 4 nm or 14 nm AuNPs were added to the cells. Cells were incubated with the AuNPs for 3 h after which cell were exposed to 4 Gy X-ray irradiation using different energies. Immediately after irradiation, culture media containing AuNPs was removed. Cells were washed once with 200 ul per well of 1x PBS and 100 ul of fresh complete growth media was added to each well. Cells were then allowed to grow under normal culture conditions (37°C, 5%CO 2 ) for 7 days after which cell proliferation was analyzed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as previously described [56] . In brief, 20 ul per well of MTT reagent (Roche Molecular Biochemicals, Indianapolis, IN) were added to the cells. After 2 h of incubation, the media containing MTT reagent was removed and cells were lysed by adding 100 ul per well of DMSO. MTT incorporation was determined by absorbance at 570 nm using the plate reader. All MTT assays were performed in 12 well replicates in each experiment, and results were normalized to untreated controls. The experiment was repeated 3 times.
Flow cytometry analysis of H2A.Xp: A total of 5 × 10 5 cells were plated in 6 well cell culture plates and cultured for 24 h. Cells were then exposed for 3 hours to 4 and 14 nm AuNPs at the concentration of 3.12 × 10 13 p/ml and 7.2 × 10 11 p/ml respectively. Cells were then irradiated with 2 Gy, 4 Gy and 8 Gy at 160 kV using a Faxitron 160 kV X-ray source, or at 2.5 FFF MV and 10 FFF MV energies using Varian Edge linear accelerator. After irradiation cells were allowed to equilibrate for 30 min at 37°C, 5%CO 2 . Cells were then washed with 1 × PBS, detached from the plates using cell detachment Accutase solution (Biolegend, San Diego, Ca) and fixed by adding ice cold 70% ethanol in a drop wise fashion, while gently vortexing. Fixation was performed overnight at -20°C. The next day cells were washed in Cell Staining Buffer (Biolegend, San Diego, CA) and incubated in 2% mouse serum for 30 minutes on ice, to block the nonspecific binding sites. Cell were then incubated with 4 ul per sample of FITC conjugated anti-human anti-H2A.X Phospho (Ser139) Mouse κ IgG1 or corresponding Mouse κ IgG1 isotype control antibody (Biolegend, San Diego, CA), on ice, in dark, for 1 hour. Cells were then washed 2x in staining buffer and the percent of cells positive for γH2AX was determined using an LSRII flow cytometer (BD Biosciences, San Jose, CA). A total of 100,000 events was acquired per sample. Data was analyzed using FACSDiva software v 8.0.1 (BD Biosciences). A live cell gate was created using the light scatter properties of the cells by plotting forward scatter (FSC; cell size) vs. side scatter (SSC; cell granularity). Cells from the live cell gate were subsequently analyzed for total γH2AX (gate P1) and additionally gated to identify a subpopulations exhibiting intense (gate P2) or moderate (gate P3) changes in fluorescence intensity.
Data analysis: Data was analyzed using GraphPad Prism by performing the unpaired Student t-Test with Sidak-Bonferroni correction. Significance was set at the p value of 0.05.
Results

AuNP characterization
Gold nanoparticles were characterized by TEM with energydispersive spectroscopy (EDAX), DLS and TGA. Images of synthesized AuNPs obtained by TEM were shown in Figure 1A . Diameters of AuNPs were determined to be 4.02 ± 0.51 nm and 14.57 ± 1.11 nm by performing at least 50 measurements per size batch (N=50). Nanoparticle chemical composition was further analyzed by EDAX that detected a peak at 2.120 eV in both, 4 nm and 14 nm AuNPs, confirming the presence of gold in the particles ( Figure 1B) . The hydrodynamic sizes of AuNPs were measured by DLS in ambient conditions and the results showed that 4 nm AuNP and 14 nm AuNP diameters were 4.2 nm and 18.7 nm, respectively ( Figure 1C) . Number based size distribution is weighted towards smaller particles while weight based distribution is weighted towards larger particles. We therefore opted to report number based distribution. As our nanoparticles were relatively uniform in size, we did not expect significant difference between these two numbers. Sizes measured by DLS are generally larger than those shown by TEM due to the inclusion of the MSA and solvent layer. To quantify the AuNPs chemical composition, TGA analysis was performed showing the weight loss of 8.61% for 4 nm AuNP and 6.41% for 14 nm AuNP ( Figure 1D ), indicating that 4 nm AuNP coating contained 248 MSA molecules while 14 nm AuNP coating contained 8584 MSA molecules. The calculation was presented in the Supplementary Material (S1).
AuNP uptake by MCF-7 cells
Radio-sensitizing potential of AuNPs strongly depends on their uptake by the cells. This internalization of AuNPs can be achieved via passive translocation across the cell membrane or through active endocytosis [33] and may be affected by variables such as nanoparticle size, shape, surface chemistry and dose [57] . We analyzed the uptake of 4 nm AuNPs and 14 nm AuNPs by the MCF-7 breast cancer cells by measuring the amount of Au inside the cells using inductively coupled plasma mass spectrometry (ICP-MS). We used two different concentrations, "low" and "high", for both 4 nm and 14 nm AuNPs. Cells were incubated with 4 nm AuNP at the concentration of 3.9 × 10 12 p/ml ("low") or 3.12 × 10 13 p/ml ("high"), and with 14 nm AuNP at the concentration of 9 × 10 10 p/ml ("low") or 7.2 × 10 11 p/ml ("high"). After 3 hours of incubation with AuNPs, cells were extensively washed to remove excess or any surface-attached nanoparticles. Cell pellets were subjected to ICP-MS to determine the total amount of intracellular gold (Figure 2A, left panel) . This data was further analyzed to quantify the amount of gold per cell and numbers of nanoparticle uptake per cell (Figure 2A, right panel) . A dose-dependent cellular intake was observed, with the "high" AuNP concentrations ensuring higher amount of total intracellular Au as well as higher numbers of AuNPs per cell, as compared to the "low" concentrations of both sizes of AuNPs used. In addition, 14 nm size AuNP exhibited higher cellular uptake then 4 nm AuNPs, as demonstrated by total intracellular Au and total numbers of AuNP per cell (Figure 2A) . To visualize the internalized particles and assess their distribution in relation to subcellular compartments, we performed TEM analysis. In TEM images, numerous high electron density-staining particles were observed inside the cells treated with AuNPs ( Figure 2C and 2D) . Clusters of dark small sized granules were also observed in control cells that were not exposed to AuNP ( Figure 2B ). However these granules exhibited less electron density than particles found in AuNP treated cells and were most likely due to glycogen deposits and ribosome structures within the cytoplasm [58] . In MCF-7 cells incubated with 4 nm AuNP, clusters of nanoparticles were seen throughout the cytoplasm with the majority of particles trapped within the membranous structures/vesicles ( Figure 2C ). These structures were found in the proximity of endoplasmic reticulum (ER) and Figure 2C . Random, cell surface AuNP localization was also observed, with some AuNPs positioned within the convoluted cell membrane processes indicative of engulfment step of an internalization process, presumably endocytosis ( Figure 2C , upper right panel). However, 4 nm AuNPs were not observed in the nuclei.
On the other hand, in MCF-7 cells incubated with 14 nm AuNPs, the majority of AuNPs were found as large aggregates within the nuclei ( Figure 2D ). These aggregates often co-localized with nucleoli ( Figure 2D , upper left and lower middle panel). Some of the AuNPs were also detected in close proximity of the nuclear membrane, in close alignment with the nuclear membrane and within the nuclear membrane invagination, altogether indicative of an engulfment step of AuNPs transport across the nuclear membrane ( Figure 2D , upper middle panel). Fourteen nm AuNPs were also found within the vesicles inside the cytoplasm, but to a less extent compared to 4 nm AuNPs ( Figure 2D , lower left panel). Random 14 nm AuNPs also exhibited engulfment by cellular membrane convolutions ( Figure 2D , lower left panel). Altogether, TEM data demonstrated MCF7 cellular uptake of AuNPs with nanoparticle size differential intracellular localization. TEM data also revealed that intracellular AuNPs deposits did not affect MCF-7 cell morphology as shown by unremarkable subcellular compartments indicative of a healthy, metabolically active cell system [59] .
Effect of AuNPs on MCF-7 cell viability after irradiation
We aimed to determine the effect of 4 nm and 14 nm AuNPs on breast cancer MCF-7 cells proliferation and response to radiation.
First, we performed a dose response experiment to determine if AuNPs had any effect on MCF-7 cells proliferation. Cells were incubated for 3 hours at 4 different concentrations with 4 nm and 14 nm AuNPs. Cells were then allowed to grow for 3 and 7 days, at which point cellular respiration, as an indicator of viable cell numbers, was determined by MTT assay [56] . Our data showed that AuNPs alone had no significant effect on MCF7 cell proliferation and the observed differences were well within the experimental error and were not AuNPs concentration or size dependent ( Figure 3A and 3B) . Hence, for further evaluation of AuNPs ability to sensitize MCF-7 to irradiation we used a single AuNP concentration, 3.12 × 10 13 p/ml for 4nm AuNP and 7.2x10 11 p/ml for 14 nm AuNP. After 3h incubation with AuNPs, cells were irradiated with 4 Gy dose using 160 kV, 2.5 FFF MV or 10FFF MV energies. Seven days later proliferation was analyzed by MTT assay. Significant enhancement of irradiation induced decrease in proliferation was observed at all irradiation energies only with 4 nm AuNP ( Figure 3C ), while with 14 nm AuNP significance was observed only at higher, 2.5 MV and 10 MV energies used ( Figure 3D ). This data indicated that the magnitude of demonstrated AuNP radio-sensitization effect in MCF-7 cells may depend on AuNP size and irradiation energy. It also supported the data from our earlier experiment that showed a lack of significant AuNP induced cytotoxicity in MCF-7 cells in the absence of radiation ( Figure 3A and 3B ).
AuNP effect on irradiation induced double strand DNA break
Exposure of cells to ionizing irradiation leads to DNA damage, with DNA double strand breaks (DSBs) being the most toxic that can lead to apoptosis. Intracellular deposition of gold NP can potentiate this effect. Here we measured the potential 4 nm or 14 nm AuNP to increase DNA histone protein H2AX phosphorylation (γH2AX), as an indicator of DNA DSBs. We analyzed the H2AX phosphorylation at three photon energies. MCF-7 cells were incubated with either 4 nm (3.12 × 10 13 p/ml) or 14 nm AuNP (7.2 × 10 11 p/ml) and irradiated with 2, 4 or 8 Gy using 160 kV, 2.5 FFF MV (60 MU/min) or 10 FFF MV (2400 MU/min) X-rays. Percent of cells positive for γH2AX was determined by flow cytometry by analyzing 100000 live cells (gate P1). In addition, cells positive for γH2AX were further gated to identify a subpopulation exhibiting brighter (gate P2) and dimmer (gate P3) fluorescence intensity. Irradiation alone using 160 kV, 2.5 FFF MV or 10 FFF MV induced an increase in the percentage of γH2AX positive cells that was irradiation dose dependent, and was manifested as an increase in FITC fluorescence exhibited as a shift to the right on histogram plots with a clearly defined increase in bright (green; P2) and dimmer (blue; P3) subpopulation. The dynamics of fluorescence changes could also be monitored on SSC vs. FSC dot plots exhibited as a change in the distribution and ratio of green (P2) vs. blue (P3) cells. At all three energies used, pretreatment with AuNP resulted in an increase in a population of γH2AX positive cells, compared to their respective controls that were exposed to irradiation only (Figures 4-6) . However, the patterns of changes were slightly different between cells treated with 4 and 14 nm AuNP and it also differed with energies and doses used for irradiation. At 160 kV pretreatment with 14 nm AuNP resulted in higher percentage of γH2AXp positive cells at all three doses of irradiation (2, 4 and 8 Gy). This effect was accompanied with a change within P2 and P3 gates and in the FCS and SSC characteristics of the cells, signifying potential changes in cell morphology ( Figure 4A and 4B) . At the same energy, cells pretreated with 4 nm AuNP exhibited the same pattern of changes except that treatment with 2 Gy resulted in only a slight increase in the percentage of γH2AX positive cells. Nevertheless, these γH2AXp positive cells still exhibited prominent increases within the P2 gate and FCS and SSC characteristics, compared to their respective irradiated controls ( Figure  4C and 4D). The lowest 2 Gy dose irradiation resulted in an appearance of clearly defined shoulder seen on FITC fluorescence histograms that was potentiated with AuNP pretreatment, indicating an increase in number of cells with brighter fluorescence intensity due to H2AX phosphorylation ( Figure 4B and 4D) . Interestingly, this effect was more pronounced in cells treated with 4 nm AuNP then in cells treated with 14 nm AuNP and it seemed to dissipate at the higher doses.
Similarly to the results observed at 160 kV, when 2.5 MV was used pretreatment with 14 nm and 4 nm AuNP resulted in a higher percentage of γH2AXp positive cells at all three doses of irradiation (2, 4 and 8 Gy) (Figure 5A-5D ). This effect was the least pronounced in cells receiving 2 Gy and 14 nm AuNP ( Figure 5A, top panel) . Again, as seen with 160 kV, the increase in percentage of γH2AXp positive cells (P1) was accompanied with an increase in P2 and P3 gates and by changes in the FCS and SSC characteristics of the cells and this was observed with both 14 and 4 nm AuNPs with all three irradiation doses applied (2, 4 and 8 Gy), but it was most pronounced in cells receiving 2 Gy and 4 nm AuNPs ( Figure 5C, top panel) . Remarkably, at 2.5 MV irradiation also resulted in an appearance of clearly defined shoulder on FITC fluorescence histograms that was potentiated with AuNP pretreatment, and was once again, more pronounced in cells treated with 4 nm AuNP then in cells treated with 14 nm AuNP.
At 10 MV energy, enrichment in γH2AXp positive cells with addition of 14 nm AuNPs was detected at all three doses used, but the most pronounced effect was observed at 4 Gy dose, manifested as an increase in the percentage of γH2AXp positive cells (P1) as well as the change in P2 and P3 (green and blue) gates ( Figure 6A and 6B) . Very similar results were observed when 4 nm AuNP were used ( Figure 6D and 6C). However, with both 4 and 14 nm AuNP the increase in the percentage of γH2AXp positive cells was the least pronounced with the dose of 8 Gy. Irradiation induced shoulder on FITC fluorescence histograms was again clearly potentiated with AuNP pretreatment and this effect was more pronounced with 4 nm AuNP. Altogether, these data indicate that AuNPs enhanced irradiation induced DNA DSBs in MCF7 cells with the most consistent effect at the dose of 4 Gy at all three energies used that was independent of nanoparticle size. Flow cytometry data is summarized in Table 1 .
Discussion
In the past decades significant advancements has been made in our understanding of breast cancer biology that has profoundly affected current treatment paradigms. However, presently available strategies for breast cancer treatment that rely on irradiation, chemotherapy and surgery, still lack specificity towards cancer cells and are associated with significant toxicity. Nanotechnology, as an emerging discipline, offers a platform for overcoming these and many other challenges associated with breast cancer treatment by introducing engineered nanomaterials that can be used to modify cancer cells responses to the applied therapies. In particular, application of gold nanoparticles as radiation sensitizers have drawn tremendous interest and have been focus of an extensive investigation in past years. However, despite convincing theoretical models and experimental validation, clinical translation to radiation protocols is missing due to insufficient understanding of the mechanisms behind AuNPs biological uptake and radiation sensitization. The inconclusiveness of extensive amount of data on these mechanisms largely stem from a wide range of AuNPs sizes, shapes and preparations as well as the biological systems studied. Despite many research efforts using various in vitro systems, little is known about the effects of AuNP in breast cancer cells. In the present study we optimized the conditions for 4 and 14 nm AuNPs cellular uptake that achieved significant radio sensitization of MCF-7 breast cancer cells exposed to the therapeutic X-rays at a range of different energies. Protocols designed for 10 MV are clinically relevant and widely used and 2.5 MV has recently been introduced to the Varian TrueBeam Linac. At the same time recent work reported promising results using 6 MV in breast and cervical cancer cell lines [28, 47, 60] , therefore in this study we opted to explore AuNP radiosensitization properties using 2.5 MV and 10 MV and bench mark it against the 160 kV energy.
One of the important aspects in identifying the optimal and clinically relevant AuNPs formulations is the size and shape of nanoparticle. In vivo bio-distribution and associated toxicity are 4 Gy 27% 20%
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8 Gy 14% 5% usually the main concerns, with larger nanoparticles (>50 nm) having a tendency for lower uptake by tumors and probable capture by liver and smaller nanoparticles (<5.5 nm) being more readily excreted by kidneys [36] . However, cellular uptake is yet another factor to be considered. A majority of studies agree that intermediate size AuNPs (20-60 nm) exhibit greatest cellular uptake [36, 61] , while smaller AuNPs (<5 nm) need to aggregate in order to be endocytosed [36, 62] . Considering all these factors we opted to use AuNPs of 4 nm and 14 nm in size, both capped by a monolayer of mercaptosuccinic acid (MSA). We showed that both, 4 nm and 14 nm size AuNPs were successfully taken up by MCF-7 cells and that their presence itself did not affect cellular morphology or function. While it was postulated that nuclear import through the nuclear pore complex is likely with nanoparticles with diameters of less than 30 nm [63] with non-targeted, passive diffusion limited to particles smaller than 9 nm [64] , in our study 4 nm AuNPs did not enter the nuclei and were found in cytoplasm only. These results were unexpected, but it is possible that aggregation of 4 nm AuNPs resulted in complexes incompatible with nuclear transport. Surprisingly, 14 nm size AuNPs not only entered the nucleus, but co-localized with nucleoli. In addition, our TEM images capturing engulfment of AuNPs by membranous structures strongly support the involvement of active vesicular transport in AuNPs passage across cellular and nuclear membranes. Although very limited number of studies explored AuNPs application in breast cancer cell lines, our data is in agreement with few reports showing uptake of 10.8 nm "naked" AuNPs and 15.6 nm PEG modified AuNPs in MCF-7 cell line [25, 38] . Given that particular intracellular AuNPs localization as well as proximity to various organelles and compartments may govern the type and magnitude of AuNPs modification of cellular responses to stress such as ionizing irradiation, our findings that 14 nm AuNPs co-localized with nucleoli within the cell nuclei may open a new line of investigation in an effort to link the AuNPs induced radiosensitization and changes at subcellular and molecular level. Designing AuNPs capable of nuclear and/or nucleolar localization may enable full exploitation of physical, chemical and biological mechanisms implicated in AuNPs radiation enhancement effect [65] . Kodiha et al. recent work in MCF-7 breast cancer cells demonstrated that 15.6 nm PEG modified AuNPs, in addition to entering the nucleus, altered the distribution and function of nucleolar and nuclear proteins important in cancer cell survival, proliferation and metabolism and these changes were significantly enhanced with heat stress [38, 66] . However, it is not known if similar mechanisms take place in irradiation induced stress. Nevertheless, the significance of our results on AuNPs co-localization with nucleoli is highlighted by the fact that nucleoli hypertrophy due to an increase in ribosome production is typical of many cancer cells [67] and it correlates with tumor malignancy, especially in breast cancer [68, 69] .
In a majority of previous studies in breast cancer in vitro and in vivo models AuNPs radio-sensitization effect was demonstrated at kV energies only. Spherical 1.9 nm AuNPs significantly improved the survival rate in mice bearing mammary EMT-6 tumors when exposed to 250 kv X-rays [24] and it reduced the survival of MDA-MB-231 breast cancer cells irradiated with 160 kV X-rays [28] . In vitro studies also showed that 10.8 nm size AuNPs significantly reduced the viability of MCF-7 breast cancer cells exposed to 160-200 kV x-rays [25, 70] . In agreement with these studies, our data showed that at 160 kV energy AuNPs decreased the proliferation of irradiated MCF-7 breast cancer cells. But, the significance was observed only with 4 nm AuNPs. While decreased cell proliferation was still detected in cells treated with 14 nm AuNPs, the reasons behind the lack of significance are unclear and require further investigation. However, kV energies are rarely used for therapeutic purposes due to the inability to penetrate deep into the body without excessive deposition to the skin and subcutaneous tissues. The majority of cancer radiation treatments rely on MV radiation protocols. Unfortunately, therapeutic radio sensitizing potential of AuNPs at clinically relevant MV energies is still controversial due to the discrepancies between theoretical models and very diverse experimental data [71] . Here we showed that at 2.5 MV and 10 MV photon energies, both 4 nm and 14 nm AuNPs induced a significant decrease in MCF-7 cell proliferation. Similarly to our results, modified thio-glucose bound AuNPs induced decrease in MCF-7 cell proliferation exposed to 6 MV [60] . In a different, MDA-MB-231 breast cancer cell line Jain et al. demonstrated AuNPs radio-sensitization at 6 MV and 15 MV photon energies [28] . Radio sensitization at MV energies has also been reported in few other cell lines and it has been suggested that AuNPs nanoscale dose effect involving Auger electrons, as well as biological effects such cell cycle impairment or ROS induced cell damage may play a role in the observed effects [72] . However the exact mechanisms behind AuNP dose enhancement in MV range are still elusive and it is not known if they may be cell specific.
Nuclear DNA has been considered as primary target of ionizing radiation, with DSBs being the most harmful damage. However, ionizing radiation induced cytotoxic pathways may be initiated at other cellular compartments such as mitochondria and nuclei [66, 73] . Early post irradiation DNA damage seemed to be directly linked to intracellular/ perinuclear AuNPs presence at the time of irradiation [74] , while the late post irradiation damage was suggested to be related to the biological mechanisms of AuNPs actions, predisposing cells to detrimental irradiation effects [72] . Many commonly used radio sensitizers enhance DNA damage by increasing DNA DSBs or inhibiting DNA repair [75] . In this work we studied the phosphorylation of H2AX, as it has previously been reported as a reliable marker for irradiation induced DNA DSBs in MCF-7 cells [76] . Here we showed that both 4 nm and 14 nm AuNPs increased radiation induced DNA DSBs. This effect was detected at both kV and MV energies used, but with most consistent changes when dose of 4 Gy was applied. While with 2 Gy dose changes were not consistent, the 8 Gy dose increased the DNA DSBs at 160 kV and 2.5 MV while at high 10 MV energy no effect was detected. It is possible that at high 10 MV using the highest 8 Gy dose already reaches the plateau in induced damages. This finding may carry clinical significance by introducing the possibility of achieving therapeutic enhancement at a lower dose when using high energies. Interestingly, we have not detected significant effect differences between 4 nm and 14 nm AuNPs. Since we were looking at the early post irradiation damage (<1 h post irradiation) the size related differences may not have been transparent. However, nuclear localization of 14 nm AuNPs opens the possibility for late post irradiation DNA damage as well. Contrary to our results, a study on MDA-MB-231 breast cancer cells showed no evidence of AuNPs enhancement of irradiation induced DNA DSBs at 6 MV and 15 MV photon energies and 4 Gy dose [28] . On the other hand, a study using HeLa cervical cancer cell line irradiated with 6 MV photon energy detected increase in DSBs using 50 nm AuNPs [47] . These discrepancies indicate possibility of differential contribution of physical, chemical and/or biological AuNPS radio-sensitization mechanisms that maybe cell type specific. Furthermore, it is possible that these mechanisms are intrinsic to cancer cells only, as work by Kong et al. showed AuNPs radio-sensitizing effect in MCF-7 breast cancer cells, but not in normal MCF-10A mammary epithelial cells [25] .
